Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03563404 · ClinicalTrials.gov registry record

Portal Blood Flushes in the Peri-Reperfusion Stage of Liver Transplantation

A clinical trial, sponsored by Medical University of South Carolina.

Completed
Registry status
20
Enrollment target

NCT03563404 is a clinical trial that has completed, run by Medical University of South Carolina. The registered enrollment target is 20 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03563404 has completed, sponsored by Medical University of South Carolina.

COMPLETED
Registry status
20 participants
Enrollment target

Study Summary

By showing that increased levels of acidotic metabolites and electrolytes in the systemic blood of patients who do not receive portal blood flush prior to reperfusion compared to patients who do receive portal blood flush, and that these increased levels correlate with cardiac depression as seen on TEE, the investigators hope to find a superior technique for liver reperfusion.

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2015-06-29
Est. Completion 2016-06-29

What the Registry Record Tells You About NCT03563404

The ClinicalTrials.gov registry entry for NCT03563404 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT03563404 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03563404 about?

NCT03563404 is a clinical study titled "Portal Blood Flushes in the Peri-Reperfusion Stage of Liver Transplantation". By showing that increased levels of acidotic metabolites and electrolytes in the systemic blood of patients who do not receive portal blood flush prior to reperfusion compared to patients who do receive portal blood flush, and that these increased levels correlate with cardiac depression as seen on ...

What is the current status of trial NCT03563404?

This trial is currently completed. The enrollment target is 20 participants. The study started on 2015-06-29. Estimated completion is 2016-06-29.

Who is sponsoring clinical trial NCT03563404?

This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.